Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,755,172
New position
Shares Held
70,447
first reported quarter
Ownership
0.242%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#50
of 211 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Irenic Capital Management LP holds $51,691,288 across 2 Biotechnology names. ANAB ranks #2 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TBPH |
Theravance Biopharma, Inc.
|
2,760,948 | $46,936,116 | |
| 2 | ANAB |
Anaptysbio, Inc
This page
|
70,447 | $4,755,172 |
All Filings in ANAB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,755,172 | 70,447 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||